CN111821376A - Chinese medicinal granule for promoting blood circulation and removing blood stasis, and its preparation method - Google Patents
Chinese medicinal granule for promoting blood circulation and removing blood stasis, and its preparation method Download PDFInfo
- Publication number
- CN111821376A CN111821376A CN201910316125.8A CN201910316125A CN111821376A CN 111821376 A CN111821376 A CN 111821376A CN 201910316125 A CN201910316125 A CN 201910316125A CN 111821376 A CN111821376 A CN 111821376A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- blood circulation
- blood stasis
- chinese medicine
- kelp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of traditional Chinese medicines, and provides a traditional Chinese medicine granule for promoting blood circulation to remove blood stasis and a preparation method thereof, wherein the traditional Chinese medicine granule is prepared from the following raw materials in parts by weight: 15-25g of sea buckthorn, 20-30g of rhizoma polygonati, 5-10g of radix polygonati officinalis, 10-15g of wolfberry fruit, 5-10g of semen cassiae, 5-10g of raspberry, 5-10g of mulberry, 4-6g of platycodon grandiflorum, 5-10g of poria cocos, 8-12g of chrysanthemum, 8-12g of honeysuckle, 8-12g of liquorice, 1-1.5g of kelp, 59-88.5g of corn starch, 10-15g of xylitol, 11-19g of maltodextrin, 10-15g of malt, 2.5-5g of L-malic acid, 1-2g of citric acid and 0.025-0.05g of stevioside. The traditional Chinese medicine granules for promoting blood circulation and removing blood stasis and the preparation method thereof have the advantages that the traditional Chinese medicine granules for promoting blood circulation and removing blood stasis can generate activated cell effect in a short time by adding the raw materials, quickly dredge capillary vessels of the whole body and activate nerves, thereby achieving the effects of removing blood stasis, promoting blood circulation and promoting aging, having quick-acting property, enabling a human body to get new in 5-10 minutes, having no toxic or side effect through clinical verification, and achieving the effects of treating both symptoms and root causes and improving symptoms.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to traditional Chinese medicine granules for promoting blood circulation to remove blood stasis and a preparation method thereof.
Background
At present, the social pressure is high, the rhythm of life is fast, coronary heart disease, hypertension, hypotension, hyperlipidemia, hyperglycemia, high blood viscosity, fatty liver, cerebral thrombosis, cerebral obstruction, encephalatrophy, facial paralysis, tongue paralysis, aphasia from apoplexy, hemiplegia, total paralysis, gynopathy, gout, diabetes, cervical vertebra and lumbar diseases, vascular sclerosis, varicosis, dizziness, headache, insomnia and dreaminess, scapulohumeral periarthritis, soreness of waist and legs, slight body fat, microcirculation disturbance and the like become multiple diseases of people, the number of people in sub-health state is increased, and the people are related to the ordinary life style of people.
However, the drug treatment process in the prior art is generally long, is easy to repeat after treatment, is not easy to eradicate, has certain drug dependence, and can relapse after drug withdrawal.
In view of the above, the present invention is particularly proposed.
Disclosure of Invention
Technical problem to be solved
According to the defects of the prior art, the traditional Chinese medicine granules for promoting blood circulation and removing blood stasis and the preparation method thereof are invented, the traditional Chinese medicine granules for promoting blood circulation and removing blood stasis are researched in the direction of pure traditional Chinese medicines, the treatment and prevention effects of the traditional Chinese medicines are improved, clinical verification proves that the traditional Chinese medicine granules have no toxic or side effect, the effective rate reaches more than 90%, the effects of combining the functions of specimens and relieving symptoms can be achieved, meanwhile, the traditional Chinese medicine granules have quick-acting performance, light diseases can be remarkably relieved after being taken for three days, and serious diseases can remarkably relieve the diseases after being taken for more than half a month.
(II) technical scheme
In order to solve the technical problems, the invention provides a preparation method of traditional Chinese medicine granules for promoting blood circulation and removing blood stasis, which has the advantages of simple operation steps, strict execution of national sanitary standard requirements during operation, close connection of the operation steps, mild operation conditions, greatly shortened operation time, saved operation cost and contribution to subsequent further expanded application, and the following technical scheme is as follows:
a traditional Chinese medicine granule for promoting blood circulation and removing blood stasis comprises the following raw materials in parts by weight: 15-25g of sea buckthorn, 20-30g of rhizoma polygonati, 5-10g of radix polygonati officinalis, 10-15g of wolfberry fruit, 5-10g of semen cassiae, 5-10g of raspberry, 5-10g of mulberry, 4-6g of platycodon grandiflorum, 5-10g of poria cocos, 8-12g of chrysanthemum, 8-12g of honeysuckle, 8-12g of liquorice, 1-1.5g of kelp, 59-88.5g of corn starch, 10-15g of xylitol, 11-19g of maltodextrin, 10-15g of malt, 2.5-5g of L-malic acid, 1-2g of citric acid and 0.025-0.05g of stevioside.
Preferably, the feed comprises the following raw materials in parts by weight: 20g of sea-buckthorn, 25g of rhizoma polygonati, 7.5g of radix polygonati officinalis, 12.5g of wolfberry fruit, 7.5g of cassia seed, 7.5g of raspberry, 7.5g of mulberry, 5g of platycodon grandiflorum, 7.5g of poria cocos, 10g of chrysanthemum, 10g of honeysuckle, 10g of liquorice, 1.25g of kelp, 73.75g of corn starch, 12.5g of xylitol, 15g of maltodextrin, 12.5g of malt, 3.75g of L-malic acid, 1.5g of citric acid and 0.0375g of stevioside.
Preferably, the feed comprises the following raw materials in parts by weight: 15g of sea-buckthorn, 20g of rhizoma polygonati, 5g of radix polygonati officinalis, 10g of wolfberry fruit, 5g of semen cassiae, 5g of raspberry, 5g of mulberry, 4g of platycodon grandiflorum, 5g of poria cocos, 8g of chrysanthemum, 8g of honeysuckle, 8g of liquorice, 1g of kelp, 59g of corn starch, 10g of xylitol, 11g of maltodextrin, 10g of malt, 2.5g of L-malic acid, 1g of citric acid and 0.025g of stevioside.
Preferably, the feed comprises the following raw materials in parts by weight: 25g of sea-buckthorn, 30g of rhizoma polygonati, 10g of radix polygonati officinalis, 15g of wolfberry fruit, 10g of semen cassiae, 10g of raspberry, 10g of mulberry, 6g of platycodon grandiflorum, 10g of poria cocos, 12g of chrysanthemum, 12g of honeysuckle, 12g of liquorice, 1.5g of kelp, 88.5g of corn starch, 15g of xylitol, 19g of maltodextrin, 15g of malt, 5g of L-malic acid, 2g of citric acid and 0.05g of stevioside.
A preparation method of traditional Chinese medicine granules for promoting blood circulation and removing blood stasis comprises the following steps:
1) sequentially cleaning 15-25g of sea buckthorn, 20-30g of rhizoma polygonati, 5-10g of radix polygonati officinalis, 10-15g of fructus lycii, 5-10g of semen cassiae, 5-10g of raspberry, 5-10g of mulberry, 4-6g of platycodon grandiflorum, 5-10g of poria cocos, 8-12g of chrysanthemum, 8-12g of honeysuckle, 8-12g of liquorice and 1-1.5g of kelp, mixing, putting into an extraction tank, adding purified water, and waiting for 30-40 min;
2) then filtering dregs of 15-25g of sea-buckthorn, 20-30g of sealwort, 5-10g of polygonatum, 10-15g of medlar, 5-10g of cassia seed, 5-10g of raspberry, 5-10g of mulberry, 4-6g of platycodon grandiflorum, 5-10g of tuckahoe, 8-12g of chrysanthemum, 8-12g of honeysuckle, 8-12g of liquorice and 1-1.5g of kelp in an extraction tank, leaving liquid medicine, standing the liquid medicine for 20-30min, filtering the liquid medicine by a filter, collecting the liquid medicine by filtering residues, concentrating the liquid medicine under reduced pressure, then adding 59-88.5g of corn starch, 10-15g of xylitol, 11-19g of maltodextrin, 10-15g of malt, 2.5-5g of L-malic acid, 1-2g of citric acid and 0.025-0.05g of stevioside for modulation, stirring with stirring rod, and granulating in granulator to obtain Chinese medicinal granule with blood circulation promoting and blood stasis removing effects.
(III) advantageous effects
Compared with the prior art, the invention has the beneficial effects that:
the traditional Chinese medicine granules for promoting blood circulation and removing blood stasis improve the treatment and prevention effects of the traditional Chinese medicine through research in the direction of pure traditional Chinese medicines, have no toxic or side effect through clinical verification, have the effective rate of more than 90 percent, can achieve the effects of treating both symptoms and root causes and improving symptoms, simultaneously have quick-acting performance, can obviously improve light diseases after being taken for three days generally, and can obviously improve heavier diseases after being taken for more than half a month generally.
The invention also provides a preparation method of the traditional Chinese medicine granules for promoting blood circulation to remove blood stasis, which has simple operation steps, strict national sanitary standard requirements during operation, close connection between the front and the back of the operation steps and mild operation conditions, greatly shortens the operation time, saves the operation cost and is beneficial to subsequent further expanded application.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without any inventive step based on the embodiments of the present invention, are within the scope of the present invention.
Example 1:
a traditional Chinese medicine granule for promoting blood circulation and removing blood stasis comprises the following raw materials in parts by weight: 20g of sea-buckthorn, 25g of rhizoma polygonati, 7.5g of radix polygonati officinalis, 12.5g of wolfberry fruit, 7.5g of cassia seed, 7.5g of raspberry, 7.5g of mulberry, 5g of platycodon grandiflorum, 7.5g of poria cocos, 10g of chrysanthemum, 10g of honeysuckle, 10g of liquorice, 1.25g of kelp, 73.75g of corn starch, 12.5g of xylitol, 15g of maltodextrin, 12.5g of malt, 3.75g of L-malic acid, 1.5g of citric acid and 0.0375g of stevioside.
A preparation method of traditional Chinese medicine granules for promoting blood circulation and removing blood stasis comprises the following steps:
1) sequentially cleaning 20g of sea buckthorn, 25g of rhizoma polygonati, 7.5g of radix polygonati officinalis, 12.5g of wolfberry fruit, 7.5g of semen cassiae, 7.5g of raspberry, 7.5g of mulberry, 5g of platycodon grandiflorum, 7.5g of poria cocos, 10g of chrysanthemum, 10g of honeysuckle, 10g of liquorice and 1.25g of kelp, mixing, putting into an extraction tank, adding purified water, and waiting for 30-40 min;
2) then filtering dregs of sea-buckthorn 20g, sealwort 25g, polygonatum 7.5g, wolfberry fruit 12.5g, cassia seed 7.5g, raspberry 7.5g, mulberry 7.5g, balloonflower 5g, poria cocos 7.5g, chrysanthemum 10g, honeysuckle 10g, licorice 10g and kelp 1.25g in an extraction tank, leaving liquid medicine, standing the liquid medicine for 20-30min, filtering by using a filter, filtering residues, collecting the liquid medicine, concentrating the liquid medicine under reduced pressure, adding corn starch 73.75g, xylitol 12.5g, maltodextrin 15g, malt 12.5g, L-malic acid 3.75g, citric acid 1.5g and stevioside 0.0375g for modulation, stirring uniformly by using a stirring rod, and putting into a granulator for granulation to prepare the traditional Chinese medicine granules for activating blood circulation and removing blood stasis.
Example 2
A traditional Chinese medicine granule for promoting blood circulation and removing blood stasis comprises the following raw materials in parts by weight: 15g of sea-buckthorn, 20g of rhizoma polygonati, 5g of radix polygonati officinalis, 10g of wolfberry fruit, 5g of semen cassiae, 5g of raspberry, 5g of mulberry, 4g of platycodon grandiflorum, 5g of poria cocos, 8g of chrysanthemum, 8g of honeysuckle, 8g of liquorice, 1g of kelp, 59g of corn starch, 10g of xylitol, 11g of maltodextrin, 10g of malt, 2.5g of L-malic acid, 1g of citric acid and 0.025g of stevioside.
A preparation method of traditional Chinese medicine granules for promoting blood circulation and removing blood stasis comprises the following steps:
1) sequentially cleaning 15g of sea buckthorn, 20g of rhizoma polygonati, 5g of radix polygonati officinalis, 10g of wolfberry fruit, 5g of semen cassiae, 5g of raspberry, 5g of mulberry, 4g of platycodon grandiflorum, 5g of poria cocos, 8g of chrysanthemum, 8g of honeysuckle, 8g of liquorice and 1g of kelp, mixing, putting into an extraction tank, adding purified water, and waiting for 30-40 min;
2) filtering residues of 15g of sea buckthorn, 20g of rhizoma polygonati, 5g of radix polygonati officinalis, 10g of wolfberry fruit, 5g of semen cassiae, 5g of raspberry, 5g of mulberry, 4g of platycodon grandiflorum, 5g of poria cocos, 8g of chrysanthemum, 8g of honeysuckle, 8g of liquorice and 1g of kelp in an extraction tank, leaving liquid medicine, standing the liquid medicine for 20-30min, filtering the liquid medicine, collecting the liquid medicine by filtering residues, concentrating the liquid medicine under reduced pressure, adding 59g of corn starch, 10g of xylitol, 11g of maltodextrin, 10g of malt, 2.5g of L-malic acid, 1g of citric acid and 0.025g of stevioside, uniformly stirring by using a stirring rod, and granulating by using a granulator to obtain the traditional Chinese medicine granules for activating blood circulation and removing blood stasis.
Example 3
A traditional Chinese medicine granule for promoting blood circulation and removing blood stasis comprises the following raw materials in parts by weight: 25g of sea-buckthorn, 30g of rhizoma polygonati, 10g of radix polygonati officinalis, 15g of wolfberry fruit, 10g of semen cassiae, 10g of raspberry, 10g of mulberry, 6g of platycodon grandiflorum, 10g of poria cocos, 12g of chrysanthemum, 12g of honeysuckle, 12g of liquorice, 1.5g of kelp, 88.5g of corn starch, 15g of xylitol, 19g of maltodextrin, 15g of malt, 5g of L-malic acid, 2g of citric acid and 0.05g of stevioside.
A preparation method of traditional Chinese medicine granules for promoting blood circulation and removing blood stasis comprises the following steps:
1) sequentially cleaning 25g of sea buckthorn, 30g of rhizoma polygonati, 10g of radix polygonati officinalis, 15g of wolfberry fruit, 10g of semen cassiae, 10g of raspberry, 10g of mulberry, 6g of platycodon grandiflorum, 10g of poria cocos, 12g of chrysanthemum, 12g of honeysuckle, 12g of liquorice and 1.5g of kelp, mixing, putting into an extraction tank, adding purified water, and waiting for 30-40 min;
2) filtering dregs of 25g of sea buckthorn, 30g of rhizoma polygonati, 10g of radix polygonati officinalis, 15g of wolfberry fruit, 10g of semen cassiae, 10g of raspberry, 10g of mulberry, 6g of platycodon grandiflorum, 10g of poria cocos, 12g of chrysanthemum, 12g of honeysuckle, 12g of liquorice and 1.5g of kelp in an extraction tank, leaving liquid medicine, standing the liquid medicine for 20-30min, filtering the liquid medicine by using a filter, filtering residues, collecting the liquid medicine, concentrating the liquid medicine under reduced pressure, adding 88.5g of corn starch, 15g of xylitol, 19g of maltodextrin, 15g of malt, 5g of L-malic acid, 2g of citric acid and 0.05g of stevioside, uniformly stirring by using a stirring rod, and granulating by using a granulator to obtain the traditional Chinese medicine granules for activating blood circulation and.
The beneficial effects of the invention are as follows: the traditional Chinese medicine granules for promoting blood circulation to remove blood stasis achieve the effect of treating diseases by adding the prepared sea buckthorn, rhizoma polygonati, radix polygonati officinalis, medlar, semen cassiae, raspberry, mulberry, platycodon grandiflorum, poria cocos, chrysanthemum, honeysuckle, liquorice, kelp, corn starch, xylitol, maltodextrin, malt, L-malic acid, citric acid and stevioside, and the traditional Chinese medicine granules can achieve the effect of treating diseases after being taken orally, are mild in medicine effect, cannot relapse after being cured, do not have any dependence, are comprehensive in effect and are outstanding in effect.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Case 1
Liu Qin, female, 46 years old, has been examined for diabetes by physical examination for 3 years. The patient likes to eat greasy food, and is suffered from coronary heart disease and hypertension which are complicated by diabetes, the patient can not be cured for a long time, the body is fat, the face is dark and yellow, the urine is frequent, the urine volume is not much, the night dreams are frequent, the night sweat, the urine is yellow, sticky and thick, the smell is fishy, the patient can not hold the urine, the patient can wet the trousers frequently, and the patient can dry and hold the stool for 1 to 3 days. After the traditional Chinese medicine granules for promoting blood circulation and removing blood stasis are used for one course of treatment, the obesity degree of the body is reduced, the face complexion is obviously improved, the sleep quality is improved, the symptoms of dreaminess are improved, the symptoms such as abnormal stool and urine are basically recovered to be normal, the intestines and stomach are also well improved, and the body is more active than the prior art.
Case 2
Lady, age 45 years, profession was lawyer. The main complaints are: palpitation and lassitude for two months.
The current medical history: two months ago, people begin to feel flustered and weak gradually, go upstairs and feel hard, and the family finds that the complexion is not as ruddy as before, and eat normally after illness, but sometimes feel uncomfortable in the upper abdomen. Food is not eaten, stool is not black, urine is normal, emaciation is slight, and the history of stomach disease does not exist.
And (3) preliminary diagnosis: climacteric syndrome
The treatment process comprises the following steps: after the diagnosis is clear, for the treatment and rehabilitation of Zhangzaozha, the traditional Chinese medicine granules for promoting blood circulation and removing blood stasis are used, after half a month of use, the phenomenon of fatigue disappears, the legs are also powerful, the biggest change is that the complexion becomes ruddy, the physical function is comprehensively improved, the sleep quality is improved, the digestive function is enhanced, and the diseases related to good appetite are improved. After one month, the skin becomes ruddy, the color development becomes black, the climacteric syndrome is obviously improved, and the blood pressure is also recovered to be normal.
Claims (5)
1. The traditional Chinese medicine granule for promoting blood circulation to remove blood stasis is characterized by comprising the following raw materials in parts by weight: 15-25g of sea buckthorn, 20-30g of rhizoma polygonati, 5-10g of radix polygonati officinalis, 10-15g of wolfberry fruit, 5-10g of semen cassiae, 5-10g of raspberry, 5-10g of mulberry, 4-6g of platycodon grandiflorum, 5-10g of poria cocos, 8-12g of chrysanthemum, 8-12g of honeysuckle, 8-12g of liquorice, 1-1.5g of kelp, 59-88.5g of corn starch, 10-15g of xylitol, 11-19g of maltodextrin, 10-15g of malt, 2.5-5g of L-malic acid, 1-2g of citric acid and 0.025-0.05g of stevioside.
2. The traditional Chinese medicine granule for promoting blood circulation to remove blood stasis as claimed in claim 1, which is characterized by comprising the following raw materials in parts by weight: 20g of sea-buckthorn, 25g of rhizoma polygonati, 7.5g of radix polygonati officinalis, 12.5g of wolfberry fruit, 7.5g of cassia seed, 7.5g of raspberry, 7.5g of mulberry, 5g of platycodon grandiflorum, 7.5g of poria cocos, 10g of chrysanthemum, 10g of honeysuckle, 10g of liquorice, 1.25g of kelp, 73.75g of corn starch, 12.5g of xylitol, 15g of maltodextrin, 12.5g of malt, 3.75g of L-malic acid, 1.5g of citric acid and 0.0375g of stevioside.
3. The traditional Chinese medicine granule for promoting blood circulation to remove blood stasis as claimed in claim 1, which is characterized by comprising the following raw materials in parts by weight: 15g of sea-buckthorn, 20g of rhizoma polygonati, 5g of radix polygonati officinalis, 10g of wolfberry fruit, 5g of semen cassiae, 5g of raspberry, 5g of mulberry, 4g of platycodon grandiflorum, 5g of poria cocos, 8g of chrysanthemum, 8g of honeysuckle, 8g of liquorice, 1g of kelp, 59g of corn starch, 10g of xylitol, 11g of maltodextrin, 10g of malt, 2.5g of L-malic acid, 1g of citric acid and 0.025g of stevioside.
4. The traditional Chinese medicine granule for promoting blood circulation to remove blood stasis as claimed in claim 1, which is characterized by comprising the following raw materials in parts by weight: 25g of sea-buckthorn, 30g of rhizoma polygonati, 10g of radix polygonati officinalis, 15g of wolfberry fruit, 10g of semen cassiae, 10g of raspberry, 10g of mulberry, 6g of platycodon grandiflorum, 10g of poria cocos, 12g of chrysanthemum, 12g of honeysuckle, 12g of liquorice, 1.5g of kelp, 88.5g of corn starch, 15g of xylitol, 19g of maltodextrin, 15g of malt, 5g of L-malic acid, 2g of citric acid and 0.05g of stevioside.
5. A preparation method of traditional Chinese medicine granules for promoting blood circulation and removing blood stasis is characterized by comprising the following steps:
1) sequentially cleaning 15-25g of sea buckthorn, 20-30g of rhizoma polygonati, 5-10g of radix polygonati officinalis, 10-15g of fructus lycii, 5-10g of semen cassiae, 5-10g of raspberry, 5-10g of mulberry, 4-6g of platycodon grandiflorum, 5-10g of poria cocos, 8-12g of chrysanthemum, 8-12g of honeysuckle, 8-12g of liquorice and 1-1.5g of kelp, mixing, putting into an extraction tank, adding purified water, and waiting for 30-40 min;
2) then filtering dregs of 15-25g of sea-buckthorn, 20-30g of sealwort, 5-10g of polygonatum, 10-15g of medlar, 5-10g of cassia seed, 5-10g of raspberry, 5-10g of mulberry, 4-6g of platycodon grandiflorum, 5-10g of tuckahoe, 8-12g of chrysanthemum, 8-12g of honeysuckle, 8-12g of liquorice and 1-1.5g of kelp in an extraction tank, leaving liquid medicine, standing the liquid medicine for 20-30min, filtering the liquid medicine by a filter, collecting the liquid medicine by filtering residues, concentrating the liquid medicine under reduced pressure, then adding 59-88.5g of corn starch, 10-15g of xylitol, 11-19g of maltodextrin, 10-15g of malt, 2.5-5g of L-malic acid, 1-2g of citric acid and 0.025-0.05g of stevioside for modulation, stirring with stirring rod, and granulating in granulator to obtain Chinese medicinal granule with blood circulation promoting and blood stasis removing effects.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910316125.8A CN111821376A (en) | 2019-04-19 | 2019-04-19 | Chinese medicinal granule for promoting blood circulation and removing blood stasis, and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910316125.8A CN111821376A (en) | 2019-04-19 | 2019-04-19 | Chinese medicinal granule for promoting blood circulation and removing blood stasis, and its preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111821376A true CN111821376A (en) | 2020-10-27 |
Family
ID=72915148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910316125.8A Pending CN111821376A (en) | 2019-04-19 | 2019-04-19 | Chinese medicinal granule for promoting blood circulation and removing blood stasis, and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111821376A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112868970A (en) * | 2021-03-18 | 2021-06-01 | 辽宁百草园饮品有限公司 | Functional plant solid beverage and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1843485A (en) * | 2005-04-07 | 2006-10-11 | 韩勇 | Powder comprising oyster and king solomonseal root |
CN102550757A (en) * | 2011-12-29 | 2012-07-11 | 郑州瑞龙制药股份有限公司 | Health-care tea |
-
2019
- 2019-04-19 CN CN201910316125.8A patent/CN111821376A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1843485A (en) * | 2005-04-07 | 2006-10-11 | 韩勇 | Powder comprising oyster and king solomonseal root |
CN102550757A (en) * | 2011-12-29 | 2012-07-11 | 郑州瑞龙制药股份有限公司 | Health-care tea |
Non-Patent Citations (1)
Title |
---|
河南钎艺食品有限公司: "沙棘黄精固体饮料", 《河南钎艺食品有限公司企业标准》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112868970A (en) * | 2021-03-18 | 2021-06-01 | 辽宁百草园饮品有限公司 | Functional plant solid beverage and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
CN104162094B (en) | A kind of Chinese medicine composition and its pharmaceutical preparation for treating Obesity-type Polycystic Ovary Syndrome | |
CN106110291A (en) | A kind of nutritional preparation for kidney cell reparation and preparation method thereof | |
CN105816617A (en) | Traditional Chinese medicine composition for treating obesity type polycystic ovarian syndrome | |
CN103735835B (en) | A kind of Chinese medicine preparation for the treatment of young person with greying hair and preparation method thereof | |
CN103041208A (en) | Chinese herbal preparation for treating climacteric syndrome of women, and preparation method thereof | |
CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
CN111821376A (en) | Chinese medicinal granule for promoting blood circulation and removing blood stasis, and its preparation method | |
CN104784538B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of diabetes | |
CN110393763A (en) | A kind of Chinese medicine composition that treating postpartum hemorrhoid, preparation method and applications | |
CN105456689A (en) | Traditional Chinese medicine composition for treating diabetes as well as preparation method and application of traditional Chinese medicine composition | |
CN104857455A (en) | Traditional Chinese medicine preparation for chronic interstitial nephropathy and preparation method thereof | |
CN104367753B (en) | A kind of Chinese medicine composition for treating diabetes B | |
CN100333779C (en) | Chinese medicine prepn for treating vaginitis and cervicitis | |
CN103330837A (en) | Traditional Chinese medicine composition for curing osteoporosis of menopausal women | |
CN103301341A (en) | Traditional Chinese medicine composition of treating ischemic cerebral apoplexy | |
CN106350411A (en) | Preparation method of healthcare wine | |
CN105833055A (en) | Traditional Chinese medicine composition for treating hypertension, hyperlipidemia and hyperglycemia and preparing method and application thereof | |
CN105194355A (en) | Traditional Chinese medicine preparation for treating primary hypertension | |
CN104623503A (en) | Traditional Chinese medicine preparation for treating hyperthyreosis and preparation process thereof | |
CN104524479A (en) | Traditional Chinese medicine composition for treating premenstrual syndrome and preparation method of traditional Chinese medicine composition | |
CN110051812A (en) | A kind of strengthening vital QI to eliminate pathogenic factors Chinese medicine and preparation method thereof | |
CN107468849A (en) | A kind of medicine for treating chronic renal failure and preparation method thereof | |
CN107854588A (en) | A kind of Chinese medicine composition for treating fatty liver and preparation method thereof | |
CN102935151B (en) | Medicine composition for protecting liver and lowering transaminase and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20201027 |
|
WD01 | Invention patent application deemed withdrawn after publication |